Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TBC1D30 |
| Upstream (Parents) |
|---|
| (<<) EIF3J → TBC1D30 |
| (<<) FLVCR2 → TBC1D30 |
| (<<) CTSL1 → TBC1D30 |
| (<<) MARCO → TBC1D30 |
| (<<) MRC1L1///MRC1 → TBC1D30 |
| (<<) VSIG4 → TBC1D30 |
| (<<) MCOLN1 → TBC1D30 |
| Downstream (Children) |
|---|
| TBC1D30 → EIF3J (>>) |
| TBC1D30 → CTNS (>>) |
| TBC1D30 → TCF12 (>>) |
| TBC1D30 → RPL5P1///RPL5P34///RPL5 (>>) |
| TBC1D30 → FAM13C (>>) |
| TBC1D30 → EXOC7 (>>) |
| TBC1D30 → PLUNC (>>) |
| TBC1D30 → FLJ41278///TBC1D30 (>>) |
| TBC1D30 → ZPBP (>>) |
| TBC1D30 → FDPS (>>) |
| TBC1D30 → RARA (>>) |
| TBC1D30 → PTCH1 (>>) |
| TBC1D30 → PER2 (>>) |
| TBC1D30 → GLUL (>>) |
